Abbott, J. M., Zhou, Q., Esquer, H., Pike, L., Broneske, T. P., Rinaldetti, S., . . . LaBarbera, D. V. (2020). First-in-Class Inhibitors of Oncogenic CHD1L With Preclinical Activity Against Colorectal Cancer. Mol Cancer Ther.
Dyfyniad Arddull ChicagoAbbott, Joshua M., et al. "First-in-Class Inhibitors of Oncogenic CHD1L With Preclinical Activity Against Colorectal Cancer." Mol Cancer Ther 2020.
Dyfyniad MLAAbbott, Joshua M., et al. "First-in-Class Inhibitors of Oncogenic CHD1L With Preclinical Activity Against Colorectal Cancer." Mol Cancer Ther 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.